Storia in 1 fonti

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

Bernstein initiated coverage of Jazz Pharmaceuticals (JAZZ) with a Market Perform rating and $229 price target The firm believes investors shou...

Raccontata da